BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,046 filers reported holding BAXTER INTL INC in Q4 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,294 | -20.7% | 98,478 | +1.4% | 0.01% | -28.6% |
Q1 2024 | $4,152 | +13.4% | 97,141 | +2.5% | 0.01% | 0.0% |
Q4 2023 | $3,662 | -3.9% | 94,733 | -6.1% | 0.01% | -12.5% |
Q3 2023 | $3,809 | -17.4% | 100,921 | -0.3% | 0.01% | -11.1% |
Q2 2023 | $4,612 | +14.7% | 101,221 | +2.1% | 0.01% | +12.5% |
Q1 2023 | $4,020 | +14.0% | 99,118 | +43.3% | 0.01% | 0.0% |
Q4 2022 | $3,525 | -99.9% | 69,175 | -13.0% | 0.01% | -27.3% |
Q3 2022 | $4,283,000 | -15.6% | 79,535 | +0.6% | 0.01% | -15.4% |
Q2 2022 | $5,077,000 | -18.8% | 79,049 | -2.0% | 0.01% | -7.1% |
Q1 2022 | $6,252,000 | -4.7% | 80,633 | +5.5% | 0.01% | -6.7% |
Q4 2021 | $6,560,000 | +3.8% | 76,428 | -2.8% | 0.02% | -6.2% |
Q3 2021 | $6,322,000 | -4.9% | 78,607 | -4.8% | 0.02% | -5.9% |
Q2 2021 | $6,649,000 | -1.4% | 82,600 | +3.3% | 0.02% | -10.5% |
Q1 2021 | $6,745,000 | +6.0% | 79,982 | +0.8% | 0.02% | 0.0% |
Q4 2020 | $6,364,000 | +2.3% | 79,321 | +2.5% | 0.02% | -9.5% |
Q3 2020 | $6,223,000 | -6.1% | 77,393 | +0.5% | 0.02% | -16.0% |
Q2 2020 | $6,629,000 | +11.7% | 76,995 | +5.3% | 0.02% | -10.7% |
Q1 2020 | $5,937,000 | -6.6% | 73,134 | -3.8% | 0.03% | +16.7% |
Q4 2019 | $6,358,000 | +1.3% | 76,038 | +6.0% | 0.02% | -11.1% |
Q3 2019 | $6,276,000 | +24.8% | 71,759 | +16.9% | 0.03% | +22.7% |
Q2 2019 | $5,028,000 | +1.7% | 61,400 | +1.0% | 0.02% | -4.3% |
Q1 2019 | $4,945,000 | +25.9% | 60,818 | +1.9% | 0.02% | +9.5% |
Q4 2018 | $3,928,000 | -20.5% | 59,691 | -6.8% | 0.02% | -12.5% |
Q3 2018 | $4,938,000 | +4.5% | 64,058 | +0.1% | 0.02% | -4.0% |
Q2 2018 | $4,727,000 | +11.9% | 64,011 | -1.5% | 0.02% | +8.7% |
Q1 2018 | $4,224,000 | -1.6% | 64,957 | -2.1% | 0.02% | 0.0% |
Q4 2017 | $4,291,000 | – | 66,380 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |